Protein Intake Tied to Modest Survival Advantage in Breast CA

Share this content:
Protein Intake Tied to Modest Survival Advantage in Breast CA
Protein Intake Tied to Modest Survival Advantage in Breast CA

THURSDAY, Nov. 10, 2016 (HealthDay News) -- For women with breast cancer, higher intake of protein is associated with a modest survival advantage, according to a study published online Nov. 7 in the Journal of Clinical Oncology.

Michelle D. Holmes, M.D., from Brigham and Women's Hospital in Boston, and colleagues examined data from 6,348 women diagnosed with stage I to III breast cancer between 1976 and 2004, with 1,046 distant recurrences. The authors calculated the relative risks for recurrence according to quintiles of post-diagnostic diet based on follow-up until 2010.

The researchers found that energy-adjusted protein intake was inversely associated with recurrence. Compared with the lowest quintile of intake, multivariable relative risks for increasing quintiles of intake were 0.95 (95 percent confidence interval [CI], 0.79 to 1.15), 0.92 (95 percent CI, 0.76 to 1.11), 0.75 (95 percent CI, 0.61 to 0.91), and 0.84 (95 percent CI, 0.69 to 1.03), respectively (P trend = 0.02). The corresponding relative risks were 0.88 (95 percent CI, 0.73 to 1.06), 0.85 (95 percent CI, 0.70 to 1.02), 0.75 (95 percent CI, 0.62 to 0.92), and 0.78 (95 percent CI, 0.63 to 0.95) (P trend = 0.003) for animal protein intake. The association was not affected by insulin receptor status. There was no clear correlation seen for any protein-containing foods.

"Our data suggest that there is likely no advantage for women with a history of breast cancer in restricting protein intake or protein-containing foods," the authors write.

Two authors disclosed financial ties to Bayer HealthCare Pharmaceuticals.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »